Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Dilation Device Treats Persistent Eustachian Tube Dysfunction

By HospiMedica International staff writers
Posted on 26 Sep 2016
A novel dilation system uses a small balloon to treat persistent Eustachian tube dysfunction (ETD), a condition in which pain and other sensations affect the ear.

The Aera Eustachian tube system consists of a balloon catheter that is inserted through the patient’s nose into the Eustachian tube. More...
After insertion, the balloon is inflated for two minutes to open up a pathway for mucus and air to flow through, in order to restore proper function and reduce pressure, pain, or clogged or muffled sensations in the ear. After the Eustachian tube is dilated, the balloon is deflated and removed. The most common adverse events are small tears of the lining of the Eustachian tube, minor bleeding, and worsening of ETD.

In a study involving 299 patients with chronic ETD, 52% of the patients treated with the Aera system had a subsequent normal functioning range as measured by a tympanogram, a method used to measure mobility of the ear drum and pressure inside the ear. The positive results were fourfold higher than in patients treated with conventional medical management using nasal sprays. The Aera system is a product of Acclarent (Menlo Park, CA, USA), and has been approved by the U.S. Food and Drug Administration (FDA).

“The Aera Eustachian tube balloon dilation system is a new treatment option for patients with ETD symptoms,” said Malvina Eydelman, MD, director of the ophthalmic & ENT device division at the FDA Center for Devices & Radiological Health (CDRH). “The Eustachian tube supports hearing by maintaining pressure inside the ear. Restoring function to this important part of the middle ear may provide relief from the pain, discomfort and sensation of ear fullness or blockage associated with ETD.”

“The Acclarent Aera offers a minimally-invasive and promising option for patients suffering from Eustachian tube dysfunction," said Juha Silvola, MD, PhD, a consultant in Otology-Otoneurology at Oslo University Hospital (Norway). “In my initial experiences with the Aera, the device enabled me to safely and successfully dilate my patients' Eustachian tubes.”

The Eustachian tube is a narrow passage leading from the pharynx to the cavity of the middle ear, permitting the equalization of pressure on each side of the eardrum. It is normally filled with air and helps maintain equal pressure inside the ear with the surrounding environment by periodically opening and closing, like a valve. If this function is impaired, as is the case with ETD, it results in discomfort, impaired hearing, persistent ear infections, ringing in the ears (tinnitus) or other symptoms.

Related Links:
Acclarent
Oslo University Hospital


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.